THINK Surgical Secures Up to $65 Million in Growth Capital from Symbiotic Capital

Jul 15, 2026
THINK Surgical has entered a debt facility with Symbiotic Capital for up to $65 million in growth capital to support the expansion of its TMINI Miniature Robotic System.

THINK Surgical has entered into a debt facility with Symbiotic Capital that will provide up to $65 million in growth capital, announced in a press release. The agreement includes an initial $25 million tranche, with an additional $15 million tied to milestones and a further $25 million available at Symbiotic Capital’s discretion.

The funds will support THINK Surgical’s dual channel commercial strategy for its TMINI Miniature Robotic System, which is compatible with about 70% of total knee implant market share. The company stated that this facility, combined with recent investor support, is expected to fund operations through profitability.

Symbiotic Capital said it was impressed by TMINI’s design and its potential to advance orthopedic surgical robotics. Piper Sandler acted as the financial advisor for THINK Surgical in this transaction.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like AI Funding Brief, Robotics Brief or Daily AI Brief.

Also, consider following us on social media:

Free newsletter

Robotics Brief

Weekly coverage of AI-driven robotics advances in industrial automation, autonomous vehicles, and robotic systems.

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more
Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.